Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1995-06-07
2000-04-11
Housel, James C.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
436543, 530350, G01N 3353, G01N 33531, C01K 100
Patent
active
060487003
ABSTRACT:
The invention provides a vaccine containing a proteinaceous material derived from the outer membrane of Bordetella pertussis, wherein the proteinaceous material is characterized by a relative molecular weight of about 67,000 to 73,000, preferably 69,000, as determined by 12% (w/w) polyacrylamide gel electrophoresis and a proline:glutamic acid ratio of about 1:1 as determined by amino acid analysis, in a pharmaceutically acceptable carrier or adjuvant. The invention also provides a method of inducing an immune response in an individual involving administering the vaccine of the invention to an individual.
REFERENCES:
patent: 4248862 (1981-02-01), Ellwood et al.
patent: 5101014 (1992-03-01), Burns et al.
patent: 5237052 (1993-08-01), Novotny
References from Prosecution of U.S. Ser. No. 08/450,336 (6 References) including: (2) Rappuoli, Rino et al., "Progress Towards the Development of New Vaccines Against Whooping Cough", Vaccines, vol. 10, Issue 14, 1992, pp. 1027-1032. (3) Sato, Hiroko et al., "Pertussis Toxin as a Protective Antigen", Bacterial Vaccines, Edited by John B. Robbins, M.D. et al., Praeger, New York, pp. 349-357. (4) Robinson, A. et al., "Pertussis Vaccines: Present Status and Futute Prospects", Vaccine, vol. 3, Mar. 1985, pp. 11-22. (5) Chazono, M. et al., "The Purification and Characterization of an Acellular Pertussis Vaccine", Journal of Biological Standardization, vol. 6, 1988, pp. 83-89. (6) Podda, Audino et al., "Phase I Clinical Trial of an Acellular . . . ", Vaccine, vol. 9, Oct. 1991, pp. 741-745.
Bernardini et al., Journ. Bact. 172:6274-6281, 1990.
Liljestrom et al., Mol. Gen. Genet., 188:184-189, 1982.
Tagliabue et al., Tokai J. Exp. Med., 13 Suppl.:253-257, 1988.
Chatfield et al., Vaccine, 7:495-498, 1989.
Corbel et al., Dev. Biol. Stand., 89:343-347, 1997.
Corbel et al., J. Med. Microbiol., 25:174-175, 1991.
Nicosia et al., Proc. Natl. Acad. Sci., 83:4631-4635, 1986.
Relman et al., Proc. Natl. Acad. Sci., 86:2637-2641, 1989.
Brown et al., Infection and Immunity, 55:154-161, 1987.
Robinson et al., Infection and Immunity, 40:523-528, 1983.
Munoz et al., Microbiol. Immunol., 33(4):341-355, 1989.
Roberts, et al., Molecular Microbiology, 5:1393-1404, 1991.
DeMagistris et al., J. Exp. Med., 168:1351-1362, 1988.
Pillemer, L., Proceedings of the Society for Experimental Biology and Medicine, 75:704-705, 1950.
Airaksinen et al., Biotechnological Letters, 13(5):305-310 (1991).
Brennan et al., Abstract B-2, Annual Meeting of American Society of Microbiology, p. 30, (1988).
Brownlie et al., Microbial Pathogenesis, 1988, 4:335-344.
Burns et al., Chemical Abstracts, 112, p. 395, Abstract No. 1048386b (Mar. 19, 1990).
Charles et al., Eur. J. Immunol., 21:1147-1153 (1991).
Charles et al., Research in Microbiology, 144(9):681-690 (1993).
Glaser et al., EMBO J., 12:3997-4004 (1988).
Gould-Kostka et al., Abstract B-126, Annual Meeting of the American Society of Microbiology, p. 51, (1989).
Gould-Kostka et al., FEMS Microbiol. Letters, 67:285-290 (Mar. 1990).
Ladant et al., The Journal of Biological Chemistry, 261:16264-16269 (1986).
Makoff et al., Bio/Technology, 8:1030-1033 (Nov. 1990).
Makoff et al., Nucleic Acids Research, 19(9):2417-2421 (1991).
Mooi et al., Infection and Immunity, 66(2):670-675 (1998).
Nara et al., The Journal of Biological Chemistry, 264:19308-19312 (1989).
Oxer et al., Nucleic Acids Research, 19(11):2889-2992 (1991).
Pagliaccia et al., Arch Microbiol., 168:437-440 (1997).
Palczewski et al., The Journal of Biological Chemistry, 263:14067-14073 (1988).
Pazirandeh et al., The Journal of Biological Chemistry, 264:18195-18201 (1989).
Pizza et al., Science, 246:497-500.
Scopes, Analytical Biochemistry, 165:235-246 (1987).
Strugnell et al., Infection and Immunity, 60(10), 3994-4002 (1992).
Swarup et al., Biochem. J., 251:569-576 (1998).
Tuomanen et al., Develop. Biol. Standard, 1985, 61:197-204.
Vose, abstract of Lecture of Dec. 1, 1989, J. Med. Microbiol., vol. 35, p. 187 (1991).
Weiss et al., Ann. Rev. Microbiol., 40:661-686 (1986).
Weiss et al., Dev. Biol. Stand., 61:11-19 (1985).
Weiss et al., Infect. and Immun., 57(12):3757-3764 (1989).
Bulletin 1107 from Bio-Rad.
Catalog of Sigma Chemical, pp. 1750-1763 (1996).
Guide to Protein Purification (Apr. 2, 1990) Methods in Enzymology, vol. 182, edited by Deutscher.
Preliminary Programme of meeting held on Dec. 1, 1989 at the National Institute for Biological Standards and Control, Potters Bar, UK.
Protein Purification Methods, A Practical Approach, edited by Harris and Angal, Oxford University Press (1989).
Deposition Transcript for Hazel Sidberry, vol. 1, May 18, 1998 (86 pages).
Deposition Transcript for Arthur Ray Crawford, vol. 1, May 22, 1998 (122 pages).
Sato et al, Infection & Immunity 29:261-266 1980.
Novotny et al Develop Biol Standard vol. 61: 27-41 (Presented at Meeting Sep. 1984.
Hewlett et al, The Journal of Infectious Disease 136: S216-S219, 1977.
Wolff et al J Biol Chem 248: 350-355, 1973.
Slungaard et al, Transactions of the Association of American Physicians. pp. 401-405, 1983.
Novotny et al The Journal of Infectious Diseases 164: 114-22, 1991.
Montaraz et al Infection & Immunity 47: 744-751, 1985.
Redhead, Infect & Immunity 44: 724-729, 1984 Serum Antibody Responses to the Outer Membrane Proteins of Bordetella pertussis.
Moss et al Annal of Internal Med 101: 653-666 1954, Presented at NIH Conf Dec. 1983.
Hewlett et al The Journal of Infectious Disease 136: S216-S219, 1977.
Taber's Cyclopedic Medical Dictionary p. 827 & 1393.
Hewlett et al., PNAS USA 73, 6, 1926-1930, 1976.
Novotny et al., Proceedings of the Third International Symposium on Pertussis, 99-123, 1979.
Endoh et al., Microbiol. Immunol. 24, 2, 95-104, 1980.
Chemical Abstracts 96, 1982, 197728e.
Confer et al., Science 217, 948-950, 1982.
Chemical Abstracts 99, 1983, 170610k.
Imaizumi et al., Infection and Immunity 41, 3, 1138-1143, 1983.
Sato et al., J. Mirobiol. Methods 1, 99-109, 1983.
Weiss et al., Infection nad Immunity 42, 1, 33-41, 1983.
Chemical Abstracts 101, 1984, 18519q.
Moss et al., Annals of Internal Medicine 101, 653-666, 1984.
Weiss et al., J. Infect. Dis. 150, 2, 219-222, Aug. 1984.
Beesley & Novotny, abstract submitted to Annual Histochemistry Meeting, Royal Microscopical Soc., U.K. Jan. 8, 1985.
Montaraz et al., Infection and Immunity 47, 3, 744-751, Mar. 1985.
Novotny et al., Proceedings of the Fourth International Symposium on Pertussis, Geneva, Switzerland, Sep. 25-27, 1984, published in Develop. Biol. Standard 61 27-41, 1986.
Hewlett et al "Soluble Adenylate Cyclase from the Culture Medium of Bordetella pertussis", J. Bacteriology, Aug. 1976 pp. 890-898.
Chemical Abstract 87:130, 172 (1977), Hewlett et al Adenyl Cyclase in Bordetella pertussis vaccines, J. Infect. Dis. 1977, 136 (Suppl.); 216-219.
Manclark et al, Bacterial Vaccine, Germonier, ed. Chapter 3, p. 72-75.
E. Hewlett et al. J.B.O. Chem., May 8, 1989, 6 pages, Adenylate Cyclase Toxin form Bordetella pertussis.
Paper-Pertussis, p. 69, Nov. 9, 1989.
Staden, Nucleic Acids Research, No. 9, 1982, pp. 2951-2961.
I.G. Charles et al. Proc. Natl. Acad. Sci. USA, vol. 86, May 1989, pp. 3554-3558, Molecular Cloning and characterization of protective outer membrane protein, p. 69 from Bordetella pertussis.
P. Glaser et al., Molecular Microbiology, 1968, 2(1), The calmodulin-sensitive adenylate cyclase of Bordetella pertussis: cloning and expression in Escherichia coli.
Hewlett et al "Soluble Adenylate Cyclase from the Culture Medium of B. pertussis" J. Bacteriol 1976 127(2) p. 890-98.
Hewlett et al "Adenylate Cyclase in B. pertussis Vaccines" CA vol. 87, 1977 #130172q.
Sato et al. "Affinity of Pertussis Toxin Produced by B. pertussis from . . . toxin". Biosis Abstract #77036164 (J. Microbiol Methods 1(12) 1983 p99.
Bacterial Vaccines by Germonier Chapter 3--Pertussis, Manclark et al p. 69-75.
C.A. vol. 101, 1984 #18519q "Bordetella adenylate cyclase toxin", Denis et al.
CA. vol. 99, 1983 #170610k "Cloning of B. pertussis DNA in E. coli cells" Senona et al.
CA. vol. 96, 1982 #197728e Separation, Purification and Properties of the F-HA and LPF-HA from B. per
Crespo Juan Antonio Montaraz
Ivanyi Juraj
Novotny Jaroslava
Novotny Pavel
Devi S.
Housel James C.
Medeva Pharma Limited
LandOfFree
Antigenic preparations and the isolation of such preparations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antigenic preparations and the isolation of such preparations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigenic preparations and the isolation of such preparations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1175520